The Goldman Sachs Group, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('GS'); return false;">GS</a>) 13D/13G Filings for Amicus Therapeutics, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('FOLD'); return false;">FOLD</a>)

The Goldman Sachs Group, Inc. 13D and 13G filings for Amicus Therapeutics, Inc.:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Shares have been adjusted for stock splits.

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2026-05-11 1:26 pm Purchase	2026-03-31	13G	AMICUS THERAPEUTICS INC FOLD	GOLDMAN SACHS GROUP INC GS	16,782,163 5.300%	16,782,163 (New Position)	Filing

The Goldman Sachs Group, Inc. (GS) 13D/13G Filings for Amicus Therapeutics, Inc. (FOLD)